CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

janssen SARS-CoV2 vaccine

Vaccineexperimental

Clinical trial activity

27 trials · 41 clinical orgs · 0 marketing orgs

Phase 1
6
Phase 2
18
Phase 3
9
Phase 4
2

Earliest trial started Jul 13, 2020 (NCT04436276)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

  3. Jan 1, 2020

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05515042Phase 2Jul 25, 2022Aurum Institute, Coalition for Epidemic Preparedness Innovations
NCT05409261Phase 2Jun 30, 2022Center for Vaccine Development CVD-Mali, Government of France, Innovative clinical research network in vaccinology (I-REIVAC), Institut National de la Santé Et de la Recherche Médicale, France, University of Paris
NCT05844202Phase 1Jun 27, 2022Alvea Holdings, LLC
NCT05220397Phase 3Apr 11, 2022Janssen Pharmaceutica NV, Mayo Clinic
NCT05109559Phase 1/Phase 2 (Phase 2)Dec 31, 2021Government of Thailand, International Vaccine Institute, Janssen Pharmaceutica NV, Mahidol University
NCT05091307Phase 3Nov 2, 2021Janssen Pharmaceutica NV
NCT05030974Phase 4Oct 31, 2021Erasmus University Rotterdam, Radboud University, University of Amsterdam, University of Groningen, ZonMw: The Netherlands Organisation for Health Research and Development
NCT05081271N/AOct 31, 2021Yale University
NCT05048940Phase 3Sep 30, 2021University of Cantabria
NCT05007080Phase 2/Phase 3 (Phase 3)Sep 27, 2021Janssen Pharmaceutica NV
NCT05037266Phase 4Sep 20, 2021Centre Hospitalier de Saint-Etienne, University of Lyon
NCT05047640Phase 3Sep 14, 2021University of Miami
NCT04765384Phase 2Aug 27, 2021Janssen Pharmaceutica NV
NCT05000216Phase 2Aug 13, 2021National Institute of Allergy and Infectious Diseases (NIAID), Northwell Health, Oklahoma Medical Research Foundation, Rho, Inc., University of Michigan, University of Pennsylvania
NCT04999111Phase 2Aug 6, 2021Janssen Pharmaceutica NV
NCT04927936N/AJun 25, 2021Erasmus University Rotterdam, Leiden University, University of Amsterdam, University of Groningen
NCT04908722Phase 3Jun 18, 2021Janssen Pharmaceutica NV
NCT05324319Phase 2Jun 15, 2021Medical University of Vienna
NCT04889209Phase 1/Phase 2 (Phase 2)May 28, 2021National Institute of Allergy and Infectious Diseases (NIAID)
NCT04894305Phase 1May 25, 2021Janssen Pharmaceutica NV
Showing 20 of 27 trials
Page 1 / 2

Organizations

Research & Development (41)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Janssen Pharmaceutica NVFor profit151242020
Erasmus University RotterdamAcademic/Hospital2122021
National Institute of Allergy and Infectious Diseases (NIAID)Government2212021
University of AmsterdamAcademic/Hospital2022021
University of GroningenAcademic/Hospital2122021
Alvea Holdings, LLCFor profit1112022
Aurum InstituteAcademic/Hospital1112022
Bio Analytical Research CorporationFor profit1012021
BiocairFor profit1012021
BioVacAcademic/Hospital1012021
Center for Vaccine Development CVD-MaliAcademic/Hospital1012022
Centre Hospitalier de Saint-EtienneAcademic/Hospital1012021
Coalition for Epidemic Preparedness InnovationsAcademic/Hospital1012022
Dis-Chem PharmacyFor profit1012021
Government of FranceGovernment1112022
government of south africaGovernment1012021
Government of ThailandGovernment1012021
Hutchinson Center Research Institute of South Africa (HCRISA)Academic/Hospital1012021
Innovative clinical research network in vaccinology (I-REIVAC)Academic/Hospital1012022
Institut National de la Santé Et de la Recherche Médicale, FranceAcademic/Hospital1012022
41 organizations
Page 1 / 3